Trade Panbela Therapeutics, Inc. - PBLA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.06 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023429% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001207% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.2 |
| Open | 1.2 |
| 1-Year Change | 34.83% |
| Day's Range | 1.07 - 1.24 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 6, 2024 | 1.08 | -0.12 | -10.00% | 1.20 | 1.25 | 1.06 |
| Mar 5, 2024 | 1.20 | 0.01 | 0.84% | 1.19 | 1.23 | 1.16 |
| Mar 4, 2024 | 1.18 | -0.06 | -4.84% | 1.24 | 1.27 | 1.16 |
| Mar 1, 2024 | 1.23 | 0.08 | 6.96% | 1.15 | 1.29 | 1.14 |
| Feb 29, 2024 | 1.14 | -0.06 | -5.00% | 1.20 | 1.22 | 1.12 |
| Feb 28, 2024 | 1.16 | -0.02 | -1.69% | 1.18 | 1.22 | 1.14 |
| Feb 27, 2024 | 1.21 | 0.08 | 7.08% | 1.13 | 1.21 | 1.13 |
| Feb 26, 2024 | 1.12 | 0.01 | 0.90% | 1.11 | 1.14 | 1.07 |
| Feb 23, 2024 | 1.09 | 0.00 | 0.00% | 1.09 | 1.11 | 1.07 |
| Feb 22, 2024 | 1.08 | -0.05 | -4.42% | 1.13 | 1.13 | 1.08 |
| Feb 21, 2024 | 1.11 | -0.05 | -4.31% | 1.16 | 1.16 | 1.11 |
| Feb 20, 2024 | 1.15 | -0.05 | -4.17% | 1.20 | 1.20 | 1.13 |
| Feb 16, 2024 | 1.22 | -0.01 | -0.81% | 1.23 | 1.29 | 1.21 |
| Feb 15, 2024 | 1.25 | -0.11 | -8.09% | 1.36 | 1.38 | 1.19 |
| Feb 14, 2024 | 1.31 | 0.21 | 19.09% | 1.10 | 1.46 | 1.10 |
| Feb 13, 2024 | 1.11 | -0.02 | -1.77% | 1.13 | 1.13 | 1.09 |
| Feb 12, 2024 | 1.16 | -0.05 | -4.13% | 1.21 | 1.21 | 1.12 |
| Feb 9, 2024 | 1.20 | 0.10 | 9.09% | 1.10 | 1.22 | 1.08 |
| Feb 8, 2024 | 1.12 | -0.02 | -1.75% | 1.14 | 1.14 | 1.05 |
| Feb 7, 2024 | 1.14 | 0.00 | 0.00% | 1.14 | 1.17 | 1.08 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Panbela Therapeutics, Inc. Company profile
About Panbela Therapeutics Inc
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing disruptive therapeutics for the treatment of patients with cancer. The Company is engaged in the commercial development of a polyamine analogue for pancreatic cancer. Its product candidate includes SBP-101, which is a proprietary polyamine analogue that accumulates in the exocrine pancreas acinar cells due to its chemical structure. The Company is conducting Phase I a/I b study of the safety, efficacy and pharmacokinetics of SBP-101 administered in combination with two standard-of-care chemotherapy agents, gemcitabine and nab-paclitaxel.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Panbela Therapeutics Inc revenues was not reported. Net loss increased 70% to $6.6M. Higher net loss reflects Research and Development - Balancing increase of 90% to $3.2M (expense), General and administrative -Bal increase of 69% to $2.5M (expense), Other income decrease from $55K (income) to $611K (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
712 Vista Blvd # 305
55387
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com